SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SARS and Avian Flu

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: tnsaf7/26/2007 12:45:10 AM
  Read Replies (1) of 4232
 
Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection

Published online before print July 17, 2007,
PNAS | July 24, 2007

Freely available online through the PNAS open access option.
pnas.org

Rachelle Salomon*, Erich Hoffmann*, and Robert G. Webster*,{dagger},{ddagger}

*Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105-2794; and {dagger}Department of Pathology, University of Tennessee, Memphis, TN 38105

Contributed by Robert G. Webster, June 5, 2007 (received for review March 29, 2007)

Because proinflammatory cytokines are markedly elevated during H5N1 influenza virus infection, the "cytokine storm" is hypothesized to be the main cause of mortality. Here, we demonstrate that mice deficient in the hallmark inflammatory cytokines TNF-{alpha}, IL-6, or CC chemokine ligand 2 succumb to infection with A/Vietnam/1203/04 (H5N1) virus, as do wild-type mice treated with glucocorticoids for suppression of cytokines. Because cytokine inhibition does not protect against death, therapies that target the virus rather than cytokines may be preferable.

Author contributions: R.S., E.H., and R.G.W. designed research; R.S. performed research; R.S., E.H., and R.G.W. analyzed data; and R.S., E.H., and R.G.W. wrote the paper.

The authors declare no conflict of interest.

{ddagger}To whom correspondence should be addressed at: Department of Infectious Diseases, St. Jude Children's Research Hospital, 332 North Lauderdale, Memphis, TN 38105-2794. E-mail: robert.webster@stjude.org

© 2007 by The National Academy of Sciences of the USA
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext